Immatics (IMTX): Proyeksi bathi mangsa ngarep

Logo perusahaan publik Immatics Corp (IMTX)

The future profitability level of Immatics N.V. (IMTX) demonstrates revenue potential from the implementation of innovative TCR drugs against solid tumors. Strategic alliances with pharma behemoths strengthen the company's market status, protecting it from price competition. The value of describes the current level of investor consensus, while the ultimate success of the business is based on the accuracy of clinical data and the scaling of personalized production.

IMTX - Bathi resik sing dikarepake immatics.com ing rentang 04.07.2022 - 16.11.2026

IMTX (Immatics Biotechnologies): rincian analitis lan laporan miturut indikator

Analisis komprehensif perusahaan:IMTX, Immatics NV
Produk dadi Immatics Corp

The aggressive hiring of leading immunologists and T-cell receptor specialists in the US and Germany directly impacts the future development costs of drugs for Immatics N.V. (IMTX). Analyzing the forward profitability trend, an investor can see the weighted average net income per share forecast, which allows for an assessment of how much the market price currently prices in the potential capitalization of scientific achievements and the business's resilience to shocks.

Analisis perusahaan pesaing

Bathi sing dikarepake NantKwest|Bathi resik sing dikarepake Immunocore IMCR|Proyeksi bathi mangsa ngarep JANX|Arcus Biosciences, Inc. (RCUS) - Proyeksi bathi resik|Zymeworks Inc - Bathi mangsa ngarep|Tango Therapeutics, Inc. (TNGX) - Bathi resik sing dikarepake|IOVA: Bathi mangsa ngarep|Penghasilan resik sing dikarepake XNCR (Xencor)|CMPX: Proyeksi bathi mangsa ngarep|REPL - Prakiraan bathi perusahaan|Bathi sing dikarepake lyell.com|Bathi mangsa ngarep innate-pharma.com (IPHA)|Bathi sing dikarepake Pyxis Oncology Inc. (PYXS)|Bathi mangsa ngarep Compugen Limited CGEN|IO Biotech Inc - Bathi mangsa ngarep|Proyeksi bathi mangsa ngarep Sutro Biopharma, Inc STRO|INKT - Bathi sing dikarepake|HOWL (Werewolf Therapeutics, Inc.) - Prakiraan bathi resik|immixbio.com (IMMX) - Bathi sing dikarepake|Bathi resik sing dikarepake ALX Oncology Holdings (ALXO)|Bathi mangsa ngarep CUE|PDSB - Proyeksi bathi resik|Bathi mangsa ngarep SONN (Sonnet BioTherapeutics)|Bathi resik mangsa ngarep MAIA|Proyeksi bathi mangsa ngarep LIMN (Liminatus Pharma LLC)|Penghasilan resik sing dikarepake LVTX|nextcure.com - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Leap Therapeutics|Intensity Tx (INTS) - Bathi sing dikarepake|Sensei Biotherapeutics Inc - Penghasilan resik sing dikarepake|TOVX (therivabio.com) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep gritstonebio.com|Bathi sing dikarepake Kineta Inc (KA)|NEXI: Bathi forward|Turnstone Biologics Corp. - Bathi mangsa ngarep|Vaccinex (VCNX) - Bathi resik sing dikarepake|Harpoon Therapeutics, Inc. - Proyeksi bathi mangsa ngarep